“Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy-Reference-Cited by-同舟云学术

“Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy

Published:2021 Issue:12 Volume:9 Page:2816-2830
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Ding Ning¹²³⁴⁵^ORCID,Xu Shengjun⁶⁷⁸⁹⁴,Zheng Sheng¹²³⁴⁵,Ye Qianwei⁶⁷⁸⁹⁴,Xu Li¹⁰¹¹⁴,Ling Sunbin⁶⁷⁸⁹⁴,Xie Shanshan¹²⁸¹³¹⁴⁴,Chen Wenwen¹²³⁴⁵,Zhang Zizhen¹²³⁴⁵,Xue Meng¹²³⁴⁵,Lin Zhenghua¹²³⁴⁵,Xu Xiao⁶⁷⁸⁹⁴,Wang Liangjing¹²³⁴⁵^ORCID

Affiliation:

1. Department of Gastroenterology

2. the Second Affiliated Hospital of Zhejiang University School of Medicine

3. Hangzhou 310020

4. China

5. Institution of Gastroenterology

6. Department of Hepatobiliary and Pancreatic Surgery

7. Affiliated Hangzhou First People's Hospital

8. Zhejiang University School of Medicine

9. Hangzhou 310006

10. NHC Key Laboratory of Combined Multi-organ Transplantation

11. Hangzhou 310003

12. The Children's Hospital

13. National Clinical Research Center for Child Health

14. Hangzhou 310052

Abstract

Motivated by the overexpression of GLUT1 in gastric cancer, a targeted SN38 prodrug delivery nanoplatform was constructed and exhibited potent antitumor efficiency, which brought a new insight to the design of nanomedicine against cancer.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D0TB02787A

Reference40 articles.

1. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

2. Cancer's sweet tooth

3. The exploits of cancer's greedy sweet-tooth